AU2001249065A1 - Method of identifying toxic agents using differential gene expression - Google Patents

Method of identifying toxic agents using differential gene expression

Info

Publication number
AU2001249065A1
AU2001249065A1 AU2001249065A AU4906501A AU2001249065A1 AU 2001249065 A1 AU2001249065 A1 AU 2001249065A1 AU 2001249065 A AU2001249065 A AU 2001249065A AU 4906501 A AU4906501 A AU 4906501A AU 2001249065 A1 AU2001249065 A1 AU 2001249065A1
Authority
AU
Australia
Prior art keywords
gene expression
differential gene
toxic agents
identifying toxic
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249065A
Inventor
Kellye K. Daniels
Vincent A. Dipippo
Bonnie E. Gould-Rothberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of AU2001249065A1 publication Critical patent/AU2001249065A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001249065A 2000-02-22 2001-02-22 Method of identifying toxic agents using differential gene expression Abandoned AU2001249065A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US18401700P 2000-02-22 2000-02-22
US60/184,017 2000-02-22
US21302700P 2000-06-21 2000-06-21
US60/213,027 2000-06-21
US23953500P 2000-10-10 2000-10-10
US60/239,535 2000-10-10
PCT/US2001/005693 WO2001063279A2 (en) 2000-02-22 2001-02-22 Method of identifying toxic agents using differential gene expression

Publications (1)

Publication Number Publication Date
AU2001249065A1 true AU2001249065A1 (en) 2001-09-03

Family

ID=27391771

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249065A Abandoned AU2001249065A1 (en) 2000-02-22 2001-02-22 Method of identifying toxic agents using differential gene expression

Country Status (3)

Country Link
US (1) US20040005537A1 (en)
AU (1) AU2001249065A1 (en)
WO (1) WO2001063279A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020065223A1 (en) * 2000-06-16 2002-05-30 Glucksmann Maria Alexandra 33358, a novel human ankyrin family member and uses thereof
US7415358B2 (en) 2001-05-22 2008-08-19 Ocimum Biosolutions, Inc. Molecular toxicology modeling
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US7469185B2 (en) 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604112A (en) * 1993-02-26 1997-02-18 The Dupont Merck Pharmaceutical Company Method for detecting the cardiotoxicity of compounds

Also Published As

Publication number Publication date
WO2001063279A3 (en) 2003-01-23
WO2001063279A2 (en) 2001-08-30
US20040005537A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2001234608A1 (en) Methods for analysis of gene expression
AU2001252973A1 (en) Biosensor and related method
AU4640400A (en) Analysis of differential protein expression
AU2002232927A1 (en) Method of providing online incentives
AU2001280968A1 (en) Compositions and methods for directed gene assembly
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2001240563A1 (en) Detection of differential gene expression
AU2001232761A1 (en) Fully-locking torque-proportioning differential
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002214126A1 (en) Genetic analysis of microorganisms
AU2001271841A1 (en) Methods for identifying combinations of drugs
AU7265298A (en) Methods and compositions for targeted dna differential display
AU2002222618A1 (en) Method of analyzing gene expression
AU2000248557A1 (en) Method of removing microbial contamination
AU2001278135A1 (en) Method of identifying immunosuppressive agents
AU2928400A (en) Analysis of differential gene expression
AU2001249065A1 (en) Method of identifying toxic agents using differential gene expression
AU1788601A (en) Method of identifying toxic agents using nsaid-induced differential gene expression in liver
AU2002252560A1 (en) Method of identifying renalgenerative agents using differential gene expression
AU2001292905A1 (en) Method of identifying osteoregenerative agents using differential gene expression
AU2002324232A1 (en) Differential gene expression in schizophrenia
EP1165825A4 (en) Toxicant-induced differential gene expression
AU2002221638A1 (en) Method for establishing germ cell-specific gene expression
AU2001257591A1 (en) Methods of identifying integrin ligands using differential gene expression
AU2001292468A1 (en) Methods and means of rna analysis